Replies to post #106630 on Amarantus Bioscience Holdings Inc (AMBS)

[sumotrader]

I don't believe it does, I can wait. It would seem unwise for Gerald to negotiate without first releasing a complete data set unlocking additional value in Lympro.

My gut says Gerald's time projections are over optimistic, I would expect a JV/partnership announcement in March 2015.

AMBS continues to de-risk it's current assets raising the probability of a $2 billion market cap two years out.

I've said it before but someone needs to introduce Gerald to Johnathan Goodman over at Knight Therapeutics (in Canada). They are sitting on $250 million in cash and scouting opportunities to partner, in-license and offer non-dilutive financing.

Sumo